Rubra Medicaments Ltd Stock Analysis

BSE: 531099 | NSE: | Trading | Small Cap

BSE Share Price 26-Dec-2022 19:03
4.50 0.00 (0.00%)

DeciZen - Make an Informed Decision on Rubra Medicaments

M-Cap below 100cr DeciZen not available

Rubra Medicaments Price Chart

P/E Ratio ( SA) :
Market Cap :
2.5 Cr.
52-wk low :
52-wk high :
Bole Toh?

1. Is Rubra Medicaments Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Rubra Medicaments Ltd is a below average quality company.

2. Is Rubra Medicaments Ltd undervalued or overvalued?

The key valuation ratios of Rubra Medicaments Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Rubra Medicaments Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Rubra Medicaments Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Rubra Medicaments:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Rubra Medicaments Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

ROCE % -1.4%-1.6%-47.7%-1.8%8.9%7.7%-22.3%1.8%0.9%-6.1%-
Value Creation Index -1.1-1.1-4.4-1.1-0.4-0.5-2.6-0.9-0.9-1.4-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 0000.
YoY Gr. Rt. %-NANANA55%641.9%-74.4%67.8%-50.5%310.2%-
Adj EPS -0.1-0.1-1.8-00.10.1-0.200-0.1-0.1
YoY Gr. Rt. %-NANANANA16.7%-442.9%NA-50%-800%-
BVPS (₹)
Adj Net Profit -0.1-0.1-1000-0.10000
Cash Flow from Ops. -0.1-0.1-0.1000.200.10.5-0.5-
Debt/CF from Ops. -3.6-4.300000000-


CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA45.3%50.5%310.2%
Adj EPS NA-203.1%NA-800%
BVPS -25.6-100.8-11.8
Share Price 1.7% -5.5% 16.2% 11.1%

Key Financial Parameters

Performance Ratio Colour Code Guide

Return on Equity % -1.5-1.7-50.6-
Op. Profit Mgn % 000-3.511.2-1.5-
Net Profit Mgn % 000-3.511.11.7-22.211.2-1.8-1.7
Debt to Equity 0.10.1000000000
Working Cap Days 00065543767314236418108268
Cash Conv. Cycle 00033-21121229419280148

Recent Performance Summary

Sales growth is good in last 4 quarters at 114.50%

Return on Equity is Poor

Sales growth has been subdued in last 3 years 0.00%

Latest Financials - Rubra Medicaments Ltd.

Standalone Consolidated
TTM EPS (₹) -0.1 -
TTM Sales (₹ Cr.) 1.9 -
BVPS (₹.) 0.5 -
Reserves (₹ Cr.) -5 -
P/BV 9.23 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 2.66 / 4.52
All Time Low / High (₹) 0.96 / 78.90
Market Cap (₹ Cr.) 2.5
Equity (₹ Cr.) 5.5
Face Value (₹) 10
Industry PE 74.5

Management X-Ray of Rubra Medicaments :

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Rubra Medicaments

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)


Rubra Medicaments Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Rubra Medicaments on 26-Dec-2022 19:03 is : 4.50.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 26-Dec-2022 19:03 the market cap of Rubra Medicaments stood at ₹ 2.46.
The latest PE ratio of Rubra Medicaments as of 26-Dec-2022 19:03 is 0.00.
The latest PB ratio of Rubra Medicaments as of 26-Dec-2022 19:03 is 9.23
The 52-week high of Rubra Medicaments is ₹ 4.52 and the 52-week low is ₹ 2.66.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue / sales of Rubra Medicaments is ₹ 1.92 ( Cr.) .

About Rubra Medicaments Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now